Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 8,000 shares at $372.75 ($3.0M) on 2019-12-13, disclosed to the SEC on 2019-12-13.
Open-market sale of $3.0M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $372.75 | 1,015 | $378K | 12.6% |
| 2 | $372.75 | 1,015 | $378K | 12.6% |
| 3 | $373.91 | 1,400 | $523K | 17.5% |
| 4 | $373.91 | 1,400 | $523K | 17.5% |
| 5 | $374.86 | 1,585 | $594K | 19.9% |
| 6 | $374.86 | 1,585 |
| $594K |
| 19.9% |
| Total | $373.99 avg | 8,000 | $3.0M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |